Interestingly CXCL10 production induced by IFNγ or cytomix is also not inhibited by current asthma therapies such as fluticasone and/or salmeterol, whereas IL-1β- and TNF-α-induced release is markedly reduced by these agents [34, 36]. Here, CXCL10 is linked to asthma.